IRON - Company ID 0001816736
The table below shows Disc Medicine, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$180.39M | -$93.93M | -$73.46M | -$42.25M | -$27.53M | -$32.71M |
| Capital expenditure | $933.00K | $505.00K | $89.00K | $151.00K | $68.00K | $22.00K |
| Investing cash flow | -$394.30M | -$292.33M | -$89.00K | -$151.00K | -$68.00K | -$22.00K |
| Dividends paid | - | - | - |
Disc Medicine, Inc. reported operating cash flow of -$180.39M for fiscal year 2025. That is down 92.1% from -$93.93M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$32.71M (FY 2020) to -$180.39M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $473.41M | $218.31M | $239.38M | $148.98M | $89.93M | $34.25M |